Rodman & Renshaw initiated its coverage of Myrexis MYRX with a Market Outperform rating and a price target of $6. On Tuesday, MYRX lost 0.57% of its value to finish the day at $3.46. Its shares rebounded in today's pre-market trading, rising 1.45% to stand around $3.51.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
